secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0001213900-26-024938
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations completes $18.6M private placement; funds expansion, FDA review mid-2026
--------------------------------------------------------------------------------

- Raised $18.6M gross via private placement of 5,774,839 shares at $3.00-$4.01 per share.
- Insiders invested $5.2M: CEO ($2.0M), Vice Chairman Moll ($2.0M), Director Adams ($1.2M).
- External investors, led by Manipal Global Health Services, invested $13.4M at $3.00/share.
- Proceeds for working capital, global expansion, and preparation for US/EU market entry.
- FDA 510(k) review for SSi Mantra system expected mid-2026; CE marking targeted in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/ea0280514-8k_ssinno.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-024938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer